臨床実務におけるスタチンの安全性
1Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford, UK. jane.armitage@ctsu.ox.ac.uk
Lancet (London, England)
|June 15, 2007
まとめ
スタチンは安全なコレステロールを下げる薬であり,心血管疾患を大幅に軽減します. 希少な筋肉や肝臓の副作用は起こりうるが,通常は中止後に回復し,スタチンはほとんどの患者にとって有益である.
科学分野:
- 薬理学 薬理学とは
- 心臓病学 心臓病学
- 薬物安全 薬物安全
背景:
- スタチンは,コレステロールを低下させ,心血管疾患を予防する主要剤です.
- 副作用は稀ですが,筋痛症,ラブドミオリシス,肝臓酵素値上昇などがあります.
研究 の 目的:
- スタチン治療の有効性および安全性プロフィールをレビューする.
- スタチンに関連した有害事象の発生率と性質を評価する.
主な方法:
- スタチンの有効性と有害事象に関する既存の文献のレビュー.
- ミオパシー,ラブドミオリシス,および肝臓トランスアミナーゼの変化の報告された症例の分析.
主要な成果:
- スタチンは,心臓発作,脳卒中,および再血管化の必要性を効果的に軽減します.
- ミオパシーとラブドミオリシスは,標準用量では稀 (<1万人に1人) で,より高い用量または薬物相互作用で増加します.
- 無症状の肝臓酵素値上昇は一般的ですが,肝臓疾患とは関係ありません.
結論:
- スタチンは一般的に安全で,ほとんどの個人によく耐えます.
- 心血管疾患の予防におけるスタチンの利点は,ほとんどの患者にとってリスクを上回ります.
- 逆戻り可能な副作用は,心血管の健康のためにスタチンを継続的に使用することを支持します.
関連する概念動画
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Drug Classes and Categories
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
Therapeutic Index
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...


